✦ LIBER ✦

Pharmacokinetics, Pharmacodynamics and Safety of Febuxostat, a Non-Purine Selective Inhibitor of Xanthine Oxidase, in a Dose Escalation Study in Healthy Subjects

✍ Scribed by Dr Reza Khosravan, Brian A. Grabowski, Jing-Tao Wu, Nancy Joseph-Ridge, Laurent Vernillet

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of hydrochlorothiazide on the pha

✍ Brian Grabowski; Reza Khosravan; Jing-Tao Wu; Laurent Vernillet; Christopher Lad 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 741 KB

Pharmacokinetics and Pharmacodynamics of

✍ Komoriya, K.; Hoshide, S.; Takeda, K.; Kobayashi, H.; Kubo, J.; Tsuchimoto, M.; 📂 Article 📅 2004 🏛 Taylor and Francis Group 🌐 English ⚖ 97 KB

Pharmacokinetics and Pharmacodynamics of

✍ K. Komoriya; S. Hoshide; K. Takeda; H. Kobayashi; J. Kubo; M. Tsuchimoto; T. Nak 📂 Article 📅 2005 🏛 John Wiley and Sons ⚖ 9 KB 👁 1 views

The Effect of Age and Gender on Pharmaco

✍ Khosravan, Reza; Kukulka, Michael J.; Wu, Jing-Tao; Joseph-Ridge, Nancy; Vernill 📂 Article 📅 2008 🏛 Sage Publications 🌐 English ⚖ 222 KB

Febuxostat (TMX-67), a Novel, Non-Purine

✍ M. A. Becker; J. Kisicki; R. Khosravan; J. Wu; D. Mulford; B. Hunt; P. MacDonald 📂 Article 📅 2005 🏛 John Wiley and Sons ⚖ 8 KB 👁 1 views

## Abstract For Abstract see ChemInform Abstract in Full Text.

Febuxostat (TMX‐67), a Novel, Non‐Purine

✍ Becker, M. A.; Kisicki, J.; Khosravan, R.; Wu, J.; Mulford, D.; Hunt, B.; MacDon 📂 Article 📅 2004 🏛 Taylor and Francis Group 🌐 English ⚖ 146 KB